Form 4: ImageneBio Director Acquires Stock Options

ImageneBio, Inc. director Otello Stampacchia acquired stock options for 15,600 shares.

Summary

• Otello Stampacchia, a Director at ImageneBio, Inc., acquired stock options on June 16, 2026.
• The options grant the right to purchase 15,600 shares of common stock at an exercise price of $5.45 per share.
• These options have an expiration date of June 16, 2036.
• The shares underlying the options vest in full upon the earlier of the first anniversary of the grant date, the Issuer's next annual meeting, or a change of control.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard insider transaction (option grant) rather than a significant financial event or strategic shift.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The acquisition of options at a specific exercise price indicates a potential for future stock appreciation.

Risks

• The vesting conditions for the stock options are tied to specific corporate events, which may or may not occur.
• The value of the stock options is dependent on the future stock price of ImageneBio, Inc.

Future Outlook

The future outlook is implicitly positive as a director has acquired options, suggesting a belief in potential stock appreciation. The vesting schedule is tied to future events, including a change of control or the company's next annual meeting.

Industry Context

StockSavvy.ai notes that director option grants are common in the biotechnology sector as a means to incentivize leadership and align their interests with shareholders, particularly in companies with long development cycles.

Stakeholder Impact

• Shareholders: The acquisition of options by a director may be viewed positively, suggesting confidence in future stock performance. However, it does not immediately impact share price or ownership structure.
• Management: Aligns management's interests with shareholders through potential future equity gains.

Next Steps

• The options will vest based on the conditions outlined in the Issuer's 2025 Equity Incentive Plan.
• Potential exercise of stock options if the stock price exceeds the exercise price of $5.45.

Key Dates

Keywords

ImageneBio, IMA, Form 4, Stock Options, Director, Beneficial Ownership, Securities, SEC Filing